Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Enuresis and voiding disorders in children

Paediatrics · Symptom or situation · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 5 to 10% of 7-year-olds, about 3% of adolescents [1]

Isolated (monosymptomatic) enuresis, healthy child

Urine tests, only in some cases

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

Enuresis with daytime symptoms, secondary enuresis or urinary tract infections

Urine tests

Blood tests, only if there is a warning sign

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Desmopressin treatment: monitoring

Only if there is a warning sign or a high-risk combination

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (6)
  1. Nevéus T, Fonseca E, Franco I, Kawauchi A, Kovacevic L, Nieuwhof-Leppink A, et al. Management and treatment of nocturnal enuresis — an updated standardization document from the International Children's Continence Society. J Pediatr Urol. 2020;16(1):10-9.
  2. National Institute for Health and Care Excellence. Bedwetting in under 19s. Clinical guideline CG111, 27 octobre 2010 (version en ligne consultée le 11 octobre 2026).
  3. National Institute for Health and Care Excellence. Urinary tract infection in under 16s: diagnosis and management. NICE guideline NG224, 27 juillet 2022.
  4. Lauters RA, Garcia KW, Arnold JJ. Enuresis in Children: Common Questions and Answers. Am Fam Physician. 2022;106(5):549-556.
  5. Radmayr C, Bogaert G, Bujons A, et al. EAU Guidelines on Paediatric Urology, chapitre 14 « Monosymptomatic nocturnal enuresis - bedwetting ». European Association of Urology, mise à jour limitée de mars 2026.
  6. ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit MINIRINMELT 120 microgrammes (desmopressine), lyophilisat oral, rubriques 4.3, 4.4, 4.5 et 4.8 (mise à jour du 7 août 2026).